Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IVA Inventiva S.A.

休市中 09-27 16:00:00 EDT

1.84

+0.05

+2.79%

盘后1.84

+0.000.00%

18:08 EDT

最高1.85	最低1.73	成交量2.18万
今开1.74	昨收1.79	日振幅6.66%
总市值9,635万	流通市值2,871万	总股本5,236万
成交额3.85万	换手率0.14%	流通股本1,560万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IVA","market":"US","secType":"STK","nameCN":"Inventiva S.A.","latestPrice":1.84,"timestamp":1727467200000,"preClose":1.79,"halted":0,"volume":21786,"hourTrading":{"tag":"盘后","latestPrice":1.84,"preClose":1.84,"latestTime":"18:08 EDT","volume":66,"amount":116.71,"timestamp":1727474903511},"delay":0,"floatShares":15604828,"shares":52361507,"eps":-2.21894,"marketStatus":"休市中","marketStatusCode":7,"change":0.05,"latestTime":"09-27 16:00:00 EDT","open":1.74,"high":1.85,"low":1.7308,"amount":38501.5546818,"amplitude":0.066592,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.21894,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1727683200000},"adr":0,"listingDate":1594353600000,"adjPreClose":1.79,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":1.84,"preClose":1.75,"latestTime":"09:28 EDT","volume":511,"amount":994.3494833999999,"timestamp":1727443717623},"postHourTrading":{"tag":"盘后","latestPrice":1.84,"preClose":1.84,"latestTime":"18:08 EDT","volume":66,"amount":116.71,"timestamp":1727474903511},"volumeRatio":1.298083204532485},"requestUrl":"/m/hq/s/IVA/tweets","defaultTab":"tweets","newsList":[{"id":"2470731457","title":"Inventiva Sa盘中异动 早盘急速下挫12.47%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470731457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470731457?lang=zh_cn&edition=full","pubTime":"2024-09-26 21:34","pubTimestamp":1727357650,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日21时34分，Inventiva Sa股票出现波动，股价大幅跳水12.47%。截至发稿，该股报1.90美元/股，成交量1.6424万股，换手率0.03%，振幅9.82%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.31%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926213410957f7a68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926213410957f7a68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","BK4139","IVA"],"gpt_icon":0},{"id":"2469242891","title":"Inventiva Sa盘中异动 临近收盘股价大涨6.82%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469242891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469242891?lang=zh_cn&edition=full","pubTime":"2024-09-24 03:41","pubTimestamp":1727120479,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日03时41分，Inventiva Sa股票出现异动，股价快速上涨6.82%。截至发稿，该股报2.19美元/股，成交量1017股，换手率0.00%，振幅2.67%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为2.73%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409240341199719c43f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409240341199719c43f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2462937391","title":"Inventiva Sa盘中异动 股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462937391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462937391?lang=zh_cn&edition=full","pubTime":"2024-08-27 21:32","pubTimestamp":1724765560,"startTime":"0","endTime":"0","summary":"北京时间2024年08月27日21时32分，Inventiva Sa股票出现波动，股价快速上涨5.42%。截至发稿，该股报2.53美元/股，成交量80股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.13%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082721324095c95bb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082721324095c95bb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2460034540","title":"Inventiva Sa盘中异动 早盘股价大涨5.91%报2.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460034540","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460034540?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:31","pubTimestamp":1724074306,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时31分，Inventiva Sa股票出现异动，股价大幅上涨5.91%。截至发稿，该股报2.33美元/股，成交量10股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.00%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921314898e3556a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921314898e3556a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139","BK4539","ALZN"],"gpt_icon":0},{"id":"2458233984","title":"Inventiva Sa盘中异动 股价大涨6.63%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458233984","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458233984?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:47","pubTimestamp":1723474020,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日22时47分，Inventiva Sa股票出现异动，股价大幅上涨6.63%。截至发稿，该股报2.25美元/股，成交量7468股，换手率0.01%，振幅5.21%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.57%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812224700aefe6d6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812224700aefe6d6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2457822028","title":"Inventiva Sa盘中异动 股价大涨5.58%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457822028","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457822028?lang=zh_cn&edition=full","pubTime":"2024-08-08 00:58","pubTimestamp":1723049931,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日00时58分，Inventiva Sa股票出现波动，股价大幅拉升5.58%。截至发稿，该股报2.27美元/股，成交量3100股，换手率0.01%，振幅1.16%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为2.24%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808005851aefdbe4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808005851aefdbe4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2457502878","title":"Inventiva Sa盘中异动 大幅跳水5.00%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457502878","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457502878?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:31","pubTimestamp":1722951092,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时31分，Inventiva Sa股票出现波动，股价大幅下跌5.00%。截至发稿，该股报2.09美元/股，成交量5352股，换手率0.01%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.14%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062131329582cb70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062131329582cb70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2455919954","title":"Inventiva Sa盘中异动 早盘快速拉升5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455919954","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455919954?lang=zh_cn&edition=full","pubTime":"2024-07-30 23:24","pubTimestamp":1722353041,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日23时24分，Inventiva Sa股票出现波动，股价大幅上涨5.33%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.21%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407302324019efe2126&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407302324019efe2126&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2454996874","title":"Inventiva Sa盘中异动 早盘股价大跌7.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454996874","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454996874?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:00","pubTimestamp":1721916006,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时00分，Inventiva Sa股票出现波动，股价大幅跳水7.20%。截至发稿，该股报2.19美元/股，成交量4561股，换手率0.01%，振幅4.24%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.65%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725220006941faa04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725220006941faa04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2454386286","title":"让办公卷入新时代，AI助手时代是否真要到来？","url":"https://stock-news.laohu8.com/highlight/detail?id=2454386286","media":"蓝鲸财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454386286?lang=zh_cn&edition=full","pubTime":"2024-07-25 09:39","pubTimestamp":1721871596,"startTime":"0","endTime":"0","summary":"从月之暗面科技的Kimi到阿里云的通义灵码，再到微软的微软智囊，每一款AI智能助手的问世，都标志着AI产品新一轮的自我突破。本文将深入探讨AI助手在现代办公中的实际应用，如何为用户提供更多元化、智能化的服务，如何为科技公司带来更广阔的市场和商业机会，以及探讨人机交互办公新时代下，AI助手最终将服务用户，还是取代用户？作为未来办公场景的变革者，AI助手正逐步突破传统办公模式，在不同维度凸显对生产力提升的辅助作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/235835","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4566","IE000W1ABFV2.USD","IE0009356076.USD","IE00B1BXHZ80.USD","IE00B19Z8X17.USD","BK4097","IE0034235303.USD","IE00B1XK9C88.USD","IE00B4YYXB79.USD","BK4567","GB00B4QBRK32.GBP","IVA","IE00BJLML261.HKD","IE00B5949003.HKD","IE00BFSS8Q28.SGD","IE00BFXG0V08.USD","IE00BLSP4239.USD","NVDA","BK4550","BK4535","IE00B3SWFQ91.USD","IE00B7KXQ091.USD","IE00BJJMRX11.SGD","IE0034235295.USD","BK4554","IE00B5TLWC47.USD","BK4516","IE00BJTD4V19.USD","BK4532","IE00B775H168.HKD","BABA","IE00BHPRN162.USD","IE0004445239.USD","MSFT","IE00BKPKM429.USD","GB00BDT5M118.USD","GB00B4LPDJ14.GBP","IE0004445015.USD","IE00BKDWB100.SGD","IE00BBT3K403.USD","BK4533","IE00BDCRKT87.USD","BK4548","IE00B775SV38.USD","IE00BK4W5M84.HKD","IE00BKVL7J92.USD","BK4538","IE00B19Z9505.USD","BK4534","IE0034235188.USD","IE00BJTD4N35.SGD","IE00B3S45H60.SGD"],"gpt_icon":1},{"id":"2453882934","title":"Inventiva Sa盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453882934","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453882934?lang=zh_cn&edition=full","pubTime":"2024-07-24 23:34","pubTimestamp":1721835286,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日23时34分，Inventiva Sa股票出现异动，股价快速下挫5.17%。截至发稿，该股报2.40美元/股，成交量2.9212万股，换手率0.06%，振幅2.77%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.50%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724233446941fa31a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724233446941fa31a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DRMA","BK4007","BK4539","IVA","BK4139"],"gpt_icon":0},{"id":"2452471822","title":"Inventiva Sa盘中异动 大幅上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452471822","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452471822?lang=zh_cn&edition=full","pubTime":"2024-07-19 21:31","pubTimestamp":1721395867,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日21时31分，Inventiva Sa股票出现异动，股价大幅拉升5.14%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.59%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407192131089f6beb52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407192131089f6beb52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2450739049","title":"Inventiva Sa盘中异动 临近收盘股价大涨7.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450739049","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450739049?lang=zh_cn&edition=full","pubTime":"2024-07-12 04:00","pubTimestamp":1720728041,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日04时00分，Inventiva Sa股票出现异动，股价大幅拉升7.28%。截至发稿，该股报2.73美元/股，成交量2.4078万股，换手率0.05%，振幅7.58%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.04%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712040041af91e4dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712040041af91e4dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2450074591","title":"Inventiva Sa盘中异动 下午盘股价大涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450074591","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450074591?lang=zh_cn&edition=full","pubTime":"2024-07-10 03:06","pubTimestamp":1720552007,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日03时06分，Inventiva Sa股票出现波动，股价大幅拉升6.08%。截至发稿，该股报2.79美元/股，成交量9789股，换手率0.02%，振幅6.84%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.39%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710030647aef8c1e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710030647aef8c1e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2449870551","title":"Inventiva Sa股价重挫11.87% 市值涨52.7万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449870551","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449870551?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:30","pubTimestamp":1720445432,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时30分，Inventiva Sa股票出现波动，股价急速下挫11.87%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Morphic Holding, Inc.、Cero Therapeutics Holdings, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为153.11%、125.81%、104.27%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Virpax Pharmaceuticals, Inc.、Prokidney Corp.，振幅分别为7.87%、5.19%、4.44%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213033aef877e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213033aef877e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","VRPX","IVA"],"gpt_icon":0},{"id":"2446841442","title":"Inventiva Sa盘中异动 早盘股价大涨6.12%报2.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446841442","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446841442?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:31","pubTimestamp":1719322278,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时31分，Inventiva Sa股票出现波动，股价快速上涨6.12%。截至发稿，该股报2.95美元/股，成交量1.4117万股，换手率0.03%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.64%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521311895d6a7ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521311895d6a7ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2445397072","title":"Inventiva Sa股价拉升13.11% 市值涨2073.11万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445397072","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445397072?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:31","pubTimestamp":1719235867,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时31分，Inventiva Sa股票出现异动，股价大幅上涨13.11%。截至发稿，该股报3.02美元/股，成交量5740股，换手率0.01%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.89%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062421310795d2b474&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062421310795d2b474&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2444214165","title":"Inventiva Sa盘中异动 快速上涨12.96%报2.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444214165","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444214165?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:31","pubTimestamp":1718890287,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时31分，Inventiva Sa股票出现异动，股价快速上涨12.96%。截至发稿，该股报2.96美元/股，成交量1963股，换手率0.00%，振幅0.38%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.13%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406202131279f52d5fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406202131279f52d5fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2444001458","title":"Inventiva Sa盘中异动 大幅拉升5.61%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444001458","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444001458?lang=zh_cn&edition=full","pubTime":"2024-06-19 00:36","pubTimestamp":1718728588,"startTime":"0","endTime":"0","summary":"北京时间2024年06月19日00时36分，Inventiva Sa股票出现异动，股价快速上涨5.61%。截至发稿，该股报2.82美元/股，成交量1.0546万股，换手率0.02%，振幅2.62%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.69%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619003628941ef444&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619003628941ef444&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2444222193","title":"Inventiva Sa盘中异动 大幅下跌5.39%报2.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444222193","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444222193?lang=zh_cn&edition=full","pubTime":"2024-06-17 22:25","pubTimestamp":1718634324,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日22时25分，Inventiva Sa股票出现波动，股价急速跳水5.39%。截至发稿，该股报2.81美元/股，成交量7181股，换手率0.01%，振幅3.03%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.26%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617222524af8de493&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617222524af8de493&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://inventivapharma.com","stockEarnings":[{"period":"1week","weight":-0.1024},{"period":"1month","weight":-0.2317},{"period":"3month","weight":-0.3846},{"period":"6month","weight":-0.4917},{"period":"1year","weight":-0.5681},{"period":"ytd","weight":-0.5926}],"compareEarnings":[{"period":"1week","weight":0.0057},{"period":"1month","weight":0.0236},{"period":"3month","weight":0.0501},{"period":"6month","weight":0.0925},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.2023}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inventiva S.A.成立于2011年，并于2016年注册成立。该公司是一家临床阶段的生物制药公司，致力于开发口服小分子疗法，以治疗非酒精性脂肪性肝炎或NASH，粘多糖酶或MPS以及其他未满足医疗需求的严重疾病。该公司建立了一个由发现引擎支持的管道，该发现引擎具有广泛的专有分子库，一个全资研发设施以及一个在开发针对核受体，转录因子和表观遗传调控的化合物方面拥有丰富专业知识和经验的团队。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.033773},{"month":2,"riseRate":0.5,"avgChangeRate":-0.02424},{"month":3,"riseRate":0,"avgChangeRate":-0.114231},{"month":4,"riseRate":0,"avgChangeRate":-0.166714},{"month":5,"riseRate":0.75,"avgChangeRate":0.155722},{"month":6,"riseRate":0.25,"avgChangeRate":-0.133608},{"month":7,"riseRate":0.25,"avgChangeRate":-0.09757},{"month":8,"riseRate":0.2,"avgChangeRate":0.009571},{"month":9,"riseRate":0.4,"avgChangeRate":-0.033084},{"month":10,"riseRate":0.75,"avgChangeRate":0.065387},{"month":11,"riseRate":0.25,"avgChangeRate":-0.033954},{"month":12,"riseRate":1,"avgChangeRate":0.075845}],"exchange":"NASDAQ","name":"Inventiva S.A.","nameEN":"Inventiva S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inventiva S.A.(IVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inventiva S.A.,IVA,Inventiva S.A.股票,Inventiva S.A.股票老虎,Inventiva S.A.股票老虎国际,Inventiva S.A.行情,Inventiva S.A.股票行情,Inventiva S.A.股价,Inventiva S.A.股市,Inventiva S.A.股票价格,Inventiva S.A.股票交易,Inventiva S.A.股票购买,Inventiva S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inventiva S.A.(IVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}